Brind.

David Reese was appointed Executive VP & CTO at Amgen on August 11, 2025.

1 report, 1 independent Updated Aug 11

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Amgen David Reese

Keep exploring

The entities involved

Amgen
American multinational biopharmaceutical company
- Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
- Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
David Reese
researcher

Nothing else this week.

Related events

Amgen Inc. trades on the NASDAQ stock exchange.Jun 7

Coverage

Newest first; wire copies grouped

Aug 11Simply Wall St.Amgen Insiders Sell US$12m Of Stock, Possibly Signalling Caution The fact that multiple Amgen Inc. (NASDAQ:AMGN) insiders offloaded a considerable amount of shares over the past year could have raise